Drug Discovery and Development Analysis & Statistics, August 2012 (p50)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

1471-1500 of about 1 600 reports

Purchase Reports From Reputable Market Research Publishers

Triple Analysis: Breast Cancer, Leukemia and Pancreatic Cancer

Triple Analysis: Breast Cancer, Leukemia and Pancreatic Cancer

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication, General Medicine and Specialty Medicine
Triple Analysis: Breast Cancer, Leukemia and Apoptosis

Triple Analysis: Breast Cancer, Leukemia and Apoptosis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Leukemia and Angiogenesis

Triple Analysis: Breast Cancer, Leukemia and Angiogenesis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lung Cancer and Lymphoma

Triple Analysis: Breast Cancer, Lung Cancer and Lymphoma

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Lymphoma. Each of these three individual parts is evaluated according to standardized criteria in a ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Triple Analysis: Breast Cancer, Lung Cancer and Pancreatic Cancer

Triple Analysis: Breast Cancer, Lung Cancer and Pancreatic Cancer

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lung Cancer and Apoptosis

Triple Analysis: Breast Cancer, Lung Cancer and Apoptosis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lung Cancer and Angiogenesis

Triple Analysis: Breast Cancer, Lung Cancer and Angiogenesis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lymphoma and Pancreatic Cancer

Triple Analysis: Breast Cancer, Lymphoma and Pancreatic Cancer

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lymphoma and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Triple Analysis: Breast Cancer, Lymphoma and Apoptosis

Triple Analysis: Breast Cancer, Lymphoma and Apoptosis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lymphoma and Angiogenesis

Triple Analysis: Breast Cancer, Lymphoma and Angiogenesis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Pancreatic Cancer and Apoptosis

Triple Analysis: Breast Cancer, Pancreatic Cancer and Apoptosis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis

Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is ...

  • Industries : Drug and Medication, General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : General Medicine and Specialty Medicine, Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis

Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Breast Cancer, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine, Therapy
Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors

Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Each of these three individual ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine, Therapy
Triple Analysis: Breast Cancer, Colorectal Cancer and Lung Cancer

Triple Analysis: Breast Cancer, Colorectal Cancer and Lung Cancer

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Lung Cancer. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Breast Cancer, Colorectal Cancer and Lymphoma

Triple Analysis: Breast Cancer, Colorectal Cancer and Lymphoma

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Lymphoma. Each of these three individual parts is evaluated according to standardized criteria ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication
Triple Analysis: Breast Cancer, Colorectal Cancer and Pancreatic Cancer

Triple Analysis: Breast Cancer, Colorectal Cancer and Pancreatic Cancer

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Pancreatic Cancer. Each of these three individual parts is evaluated according to standardized ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Drug and Medication, Drug Discovery and Development
Triple Analysis: Breast Cancer, Colorectal Cancer and Apoptosis

Triple Analysis: Breast Cancer, Colorectal Cancer and Apoptosis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Colorectal Cancer and Angiogenesis

Triple Analysis: Breast Cancer, Colorectal Cancer and Angiogenesis

  • $ 5 175
  • Industry report
  • August 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Global Contract Research Organization Market 2011-2015

Global Contract Research Organization Market 2011-2015

  • $ 2 000
  • Industry report
  • August 2012
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Contract Research Organization (CRO) market to grow at a CAGR of 10.7 percent over the period 2011-2015. One of the key factors contributing to this market growth ...

  • Industries : Pharmaceutical
  • Countries : World
e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies

  • $ 3 500
  • Industry report
  • July 2012
  • by GBI Research

e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies Summary GBI Research, the ...

  • Industries : Drug Discovery and Development
  • Countries : World
Global High Content Screening (HCS) Industry

Global High Content Screening (HCS) Industry

  • $ 4 450
  • Industry report
  • July 2012
  • by Global Industry Analysts

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual ...

  • Industries : Drug Discovery and Development
  • Countries : World
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles Summary GBI Research in its report “Endpoints - ...

  • Industries : Pathology
  • Countries : World
Indian Bioinformatics Market Forecast to 2015

Indian Bioinformatics Market Forecast to 2015

  • $ 500
  • Industry report
  • May 2012
  • by RNCOS

Bioinformatics is one of the fastest emerging interdisciplinary research areas, which may be defined as an ‘interface between biological and computational sciences’. Most of the Bioinformatics work ...

  • Industries : Drug Discovery and Development
  • Countries : India
Triple Analysis: Leukemia, Apoptosis and Protein Kinase Inhibitors

Triple Analysis: Leukemia, Apoptosis and Protein Kinase Inhibitors

  • $ 5 175
  • Company report
  • May 2012
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Each of these three individual parts ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Therapy, Drug Discovery and Development

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.